Confident that bulk RNA-seq analysis could capture changes in hepatocyte Smo expression, we performed high-throughput RNA-seq on liver samples collected from 368 patients suspected of having NASH fibrosis who underwent a diagnostic liver biopsy. Here, SMO is linked to metabolic dysfunction-associated steatohepatitis.